Voleon Capital Management’s 10x Genomics TXG Stock Holding History

Voleon Capital Management’s Portfolio TXG Stock Details TXG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$212K	Sell	5,520 -6,784	-55%	-$178K	﹤0.01%	725
2026 Q1	$261K	Sell	12,304 -74,138	-86%	-$1.48M	0.01%	690
2025 Q4	$1.41M	Sell	86,442 -219,659	-72%	-$3.32M	0.03%	387
2025 Q3	$3.58M	Buy	306,101 +130,094	+74%	+$1.7M	0.09%	231
2025 Q2	$2.04M	Buy	176,007 +78,856	+81%	+$719K	0.11%	174
2025 Q1	$848K	Buy	97,151 +82,857	+580%	+$1.04M	0.07%	221
2024 Q4	$205K	Buy	+14,294	New	+$226K	0.02%	313

Other funds holding TXG

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

QCM

Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Voleon Capital Management's TXG Position: Q2 2026 in Review

Voleon Capital Management reduced its 10x Genomics (TXG) stake by 55% in Q2 2026, selling an estimated $178K and leaving 5,520 shares worth $212K. The position accounts for ﹤0.01% of the portfolio, ranked #725.

Voleon Capital Management first reported a position in TXG in Q4 2024 and has held it in 7 quarters since. The position peaked at $3.58M in Q3 2025. 392 funds tracked by Wall St. Rank hold TXG as of Q2 2026.

Voleon Capital Management held 5,520 shares of 10x Genomics worth $212K as of Q2 2026.
Voleon Capital Management sold 6,784 10x Genomics shares in Q2 2026, an estimated $178K.
10x Genomics made up ﹤0.01% of Voleon Capital Management's portfolio in Q2 2026, its #725 holding.
Voleon Capital Management first reported a position in 10x Genomics in Q4 2024 and has held it in 7 quarters since.
Voleon Capital Management's 10x Genomics position peaked at $3.58M in Q3 2025.
392 funds tracked by Wall St. Rank held 10x Genomics as of Q2 2026.

Based on Voleon Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.